-
1
-
-
84859012407
-
Diabetic retinopathy
-
Antonetti, D. A., Klein, R. & Gardner, T. W. Diabetic retinopathy. N Engl J Med 366, 1227-1239 (2012).
-
(2012)
N Engl J Med
, vol.366
, pp. 1227-1239
-
-
Antonetti, D.A.1
Klein, R.2
Gardner, T.W.3
-
2
-
-
85047690920
-
SDF-1 is both necessary and sufficient to promote proliferative retinopathy
-
Butler, J. M. et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 115, 86-93 (2005).
-
(2005)
J Clin Invest
, vol.115
, pp. 86-93
-
-
Butler, J.M.1
-
4
-
-
78651362828
-
Stromal cell-derived factor-1 (SDF-1): Homing factor for engineered regenerative medicine
-
Lau, T. T. & Wang, D. A. Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin Biol Ther 11, 189-197 (2011).
-
(2011)
Expert Opin Biol Ther
, vol.11
, pp. 189-197
-
-
Lau, T.T.1
Wang, D.A.2
-
5
-
-
84930194559
-
A critical role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart
-
Cheng, M. et al. A critical role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart. J Mol Cell Cardiol 81, 49-53 (2015).
-
(2015)
J Mol Cell Cardiol
, vol.81
, pp. 49-53
-
-
Cheng, M.1
-
6
-
-
78349309965
-
CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity
-
Cheng, M. et al. CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity. Circ Res 107, 1083-1093 (2010).
-
(2010)
Circ Res
, vol.107
, pp. 1083-1093
-
-
Cheng, M.1
-
7
-
-
0034268796
-
Src tyrosine kinase is a novel direct effector of G proteins
-
Ma, Y. C., Huang, J., Ali, S., Lowry, W. & Huang, X. Y. Src tyrosine kinase is a novel direct effector of G proteins. Cell 102, 635-646 (2000).
-
(2000)
Cell
, vol.102
, pp. 635-646
-
-
Ma, Y.C.1
Huang, J.2
Ali, S.3
Lowry, W.4
Huang, X.Y.5
-
8
-
-
33847050140
-
Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: Identification of tyrosine 685 as the unique target site
-
Wallez, Y. et al. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 26, 1067-1077 (2007).
-
(2007)
Oncogene
, vol.26
, pp. 1067-1077
-
-
Wallez, Y.1
-
9
-
-
14044256553
-
Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues
-
Lambeng, N. et al. Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues. Circ Res 96, 384-391 (2005).
-
(2005)
Circ Res
, vol.96
, pp. 384-391
-
-
Lambeng, N.1
-
10
-
-
0142210188
-
Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation
-
Lin, M. T., Yen, M. L., Lin, C. Y. & Kuo, M. L. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol 64, 1029-1036 (2003).
-
(2003)
Mol Pharmacol
, vol.64
, pp. 1029-1036
-
-
Lin, M.T.1
Yen, M.L.2
Lin, C.Y.3
Kuo, M.L.4
-
11
-
-
32244434845
-
Angiogenesis: The VE-cadherin switch
-
Wallez, Y., Vilgrain, I. & Huber, P. Angiogenesis: the VE-cadherin switch. Trends Cardiovasc Med 16, 55-59 (2006).
-
(2006)
Trends Cardiovasc Med
, vol.16
, pp. 55-59
-
-
Wallez, Y.1
Vilgrain, I.2
Huber, P.3
-
12
-
-
0029085510
-
Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin
-
Breviario, F. et al. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler Thromb Vasc Biol 15, 1229-1239 (1995).
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 1229-1239
-
-
Breviario, F.1
-
13
-
-
0032776062
-
Vascular-endothelial-cadherin modulates endothelial monolayer permeability
-
Hordijk, P. L. et al. Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci 112 (Pt 12), 1915-1923 (1999).
-
(1999)
J Cell Sci
, vol.112
, pp. 1915-1923
-
-
Hordijk, P.L.1
-
14
-
-
0035869433
-
Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability
-
Corada, M. et al. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood 97, 1679-1684 (2001).
-
(2001)
Blood
, vol.97
, pp. 1679-1684
-
-
Corada, M.1
-
15
-
-
36649018946
-
Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice
-
Sasaki, T. et al. Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice. Pediatr Int 49, 966-971 (2007).
-
(2007)
Pediatr Int
, vol.49
, pp. 966-971
-
-
Sasaki, T.1
-
16
-
-
0041327804
-
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy
-
Askari, A. T. et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362, 697-703 (2003).
-
(2003)
Lancet
, vol.362
, pp. 697-703
-
-
Askari, A.T.1
-
17
-
-
58149345104
-
IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair
-
Haider, H., Jiang, S., Idris, N. M. & Ashraf, M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103, 1300-1308 (2008).
-
(2008)
Circ Res
, vol.103
, pp. 1300-1308
-
-
Haider, H.1
Jiang, S.2
Idris, N.M.3
Ashraf, M.4
-
18
-
-
84878217732
-
Vascular permeability changes involved in tumor metastasis
-
Garcia-Roman, J. & Zentella-Dehesa, A. Vascular permeability changes involved in tumor metastasis. Cancer Lett 335, 259-269 (2013).
-
(2013)
Cancer Lett
, vol.335
, pp. 259-269
-
-
Garcia-Roman, J.1
Zentella-Dehesa, A.2
-
19
-
-
33748041454
-
Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy
-
You, D. et al. Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy. Circulation 114, 328-338 (2006).
-
(2006)
Circulation
, vol.114
, pp. 328-338
-
-
You, D.1
-
20
-
-
62949195390
-
Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction
-
Zaruba, M. M. et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 4, 313-323 (2009).
-
(2009)
Cell Stem Cell
, vol.4
, pp. 313-323
-
-
Zaruba, M.M.1
-
21
-
-
44549085494
-
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function
-
Ohnuma, K., Dang, N. H. & Morimoto, C. Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Trends Immunol 29, 295-301 (2008).
-
(2008)
Trends Immunol
, vol.29
, pp. 295-301
-
-
Ohnuma, K.1
Dang, N.H.2
Morimoto, C.3
-
22
-
-
13144283654
-
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
-
Shioda, T. et al. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc Natl Acad Sci USA 95, 6331-6336 (1998).
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 6331-6336
-
-
Shioda, T.1
-
23
-
-
0035839639
-
Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family
-
Lambeir, A. M. et al. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem 276, 29839-29845 (2001).
-
(2001)
J Biol Chem
, vol.276
, pp. 29839-29845
-
-
Lambeir, A.M.1
-
24
-
-
0037114177
-
Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/ stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells
-
Christopherson, K. W., 2nd, Hangoc, G. & Broxmeyer, H. E. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/ stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 169, 7000-7008 (2002).
-
(2002)
J Immunol
, vol.169
, pp. 7000-7008
-
-
Christopherson, K.W.1
Hangoc, G.2
Broxmeyer, H.E.3
-
25
-
-
84883419226
-
Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types
-
Ou, X., O'Leary, H. A. & Broxmeyer, H. E. Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types. Blood 122, 161-169 (2013).
-
(2013)
Blood
, vol.122
, pp. 161-169
-
-
Ou, X.1
O'Leary, H.A.2
Broxmeyer, H.E.3
-
26
-
-
84863823133
-
CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation
-
Jungraithmayr, W. et al. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. Eur J Cardiothorac Surg 41, 1166-1173 (2012).
-
(2012)
Eur J Cardiothorac Surg
, vol.41
, pp. 1166-1173
-
-
Jungraithmayr, W.1
-
27
-
-
80052790933
-
Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium
-
Kanki, S. et al. Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium. Circ Heart Fail 4, 509-518 (2011).
-
(2011)
Circ Heart Fail
, vol.4
, pp. 509-518
-
-
Kanki, S.1
-
28
-
-
77958195997
-
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: Possible role of stromal-derived factor-1alpha
-
Fadini, G. P. et al. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. Diabetes Care 33, 1607-1609 (2010).
-
(2010)
Diabetes Care
, vol.33
, pp. 1607-1609
-
-
Fadini, G.P.1
-
29
-
-
84896883898
-
DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via upregulation of SDF-1alpha in type 2 diabetic patients with incipient nephropathy
-
Fujita, H. et al. DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via upregulation of SDF-1alpha in type 2 diabetic patients with incipient nephropathy. Endocr J 61, 159-166 (2014).
-
(2014)
Endocr J
, vol.61
, pp. 159-166
-
-
Fujita, H.1
-
30
-
-
70350015332
-
The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species
-
Monaghan-Benson, E. & Burridge, K. The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 284, 25602-25611 (2009).
-
(2009)
J Biol Chem
, vol.284
, pp. 25602-25611
-
-
Monaghan-Benson, E.1
Burridge, K.2
-
31
-
-
24744449317
-
Tyrosine phosphorylation of VE-cadherin prevents binding of p120-and beta-catenin and maintains the cellular mesenchymal state
-
Potter, M. D., Barbero, S. & Cheresh, D. A. Tyrosine phosphorylation of VE-cadherin prevents binding of p120-and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 280, 31906-31912 (2005).
-
(2005)
J Biol Chem
, vol.280
, pp. 31906-31912
-
-
Potter, M.D.1
Barbero, S.2
Cheresh, D.A.3
-
32
-
-
32844473903
-
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers
-
Bergman, A. J. et al. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers. Clin Ther 28, 55-72 (2006).
-
(2006)
Clin Ther
, vol.28
, pp. 55-72
-
-
Bergman, A.J.1
-
33
-
-
0025913788
-
Specific proto-oncogenic tyrosine kinases of src family are enriched in cell-to-cell adherens junctions where the level of tyrosine phosphorylation is elevated
-
Tsukita, S. et al. Specific proto-oncogenic tyrosine kinases of src family are enriched in cell-to-cell adherens junctions where the level of tyrosine phosphorylation is elevated. J Cell Biol 113, 867-879 (1991).
-
(1991)
J Cell Biol
, vol.113
, pp. 867-879
-
-
Tsukita, S.1
-
34
-
-
18944388292
-
Association of Csk to VE-cadherin and inhibition of cell proliferation
-
Baumeister, U. et al. Association of Csk to VE-cadherin and inhibition of cell proliferation. EMBO J 24, 1686-1695 (2005).
-
(2005)
EMBO J
, vol.24
, pp. 1686-1695
-
-
Baumeister, U.1
-
35
-
-
84878023363
-
Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC
-
Birukova, A. A. et al. Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC. Transl Res 161, 495-504 (2013).
-
(2013)
Transl Res
, vol.161
, pp. 495-504
-
-
Birukova, A.A.1
-
36
-
-
84894470051
-
Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VEcadherin
-
Wessel, F. et al. Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VEcadherin. Nat Immunol 15, 223-230 (2014).
-
(2014)
Nat Immunol
, vol.15
, pp. 223-230
-
-
Wessel, F.1
-
37
-
-
84887212399
-
The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells
-
Alghisi, G. C., Ponsonnet, L. & Ruegg, C. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS One 4, e4449 (2009).
-
(2009)
PLoS One
, vol.4
, pp. e4449
-
-
Alghisi, G.C.1
Ponsonnet, L.2
Ruegg, C.3
-
38
-
-
84906546746
-
Blood pressure and amiloride-sensitive sodium channels in vascular and renal cells
-
Warnock, D. G. et al. Blood pressure and amiloride-sensitive sodium channels in vascular and renal cells. Nat Rev Nephrol 10, 146-157 (2014).
-
(2014)
Nat Rev Nephrol
, vol.10
, pp. 146-157
-
-
Warnock, D.G.1
-
39
-
-
84856408598
-
A role for VEGFR2 activation in endothelial responses caused by barrier disruptive OxPAPC concentrations
-
Birukova, A. A. et al. A role for VEGFR2 activation in endothelial responses caused by barrier disruptive OxPAPC concentrations. PLoS One 7, e30957 (2012).
-
(2012)
PLoS One
, vol.7
, pp. e30957
-
-
Birukova, A.A.1
-
40
-
-
77951212625
-
Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers
-
Adam, A. P., Sharenko, A. L., Pumiglia, K. & Vincent, P. A. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. J Biol Chem 285, 7045-7055 (2010).
-
(2010)
J Biol Chem
, vol.285
, pp. 7045-7055
-
-
Adam, A.P.1
Sharenko, A.L.2
Pumiglia, K.3
Vincent, P.A.4
-
41
-
-
0021061379
-
Animal models of diabetes mellitus: Physiology and pathology
-
Bell, R. H., Jr. & Hye, R. J. Animal models of diabetes mellitus: physiology and pathology. J Surg Res 35, 433-460 (1983).
-
(1983)
J Surg Res
, vol.35
, pp. 433-460
-
-
Bell, R.H.1
Hye, R.J.2
-
42
-
-
0027982899
-
Oxygen-induced retinopathy in the mouse
-
Smith, L. E. et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35, 101-111 (1994).
-
(1994)
Invest Ophthalmol Vis Sci
, vol.35
, pp. 101-111
-
-
Smith, L.E.1
-
43
-
-
84978053609
-
Noncardiac Pulmonary Edema induced by Sitagliptin Treatment
-
Belice, T., Yuce, S., Kizilkaya, B., Kurt, A. & Cure, E. Noncardiac Pulmonary Edema induced by Sitagliptin Treatment. J Family Med Prim Care 3, 456-457 (2014).
-
(2014)
J Family Med Prim Care
, vol.3
, pp. 456-457
-
-
Belice, T.1
Yuce, S.2
Kizilkaya, B.3
Kurt, A.4
Cure, E.5
-
44
-
-
84859092128
-
RS3PE in association with dipeptidyl peptidase-4 inhibitor: Report of two cases
-
Yamauchi, K. et al. RS3PE in association with dipeptidyl peptidase-4 inhibitor: report of two cases. Diabetes Care 35, e7 (2012).
-
(2012)
Diabetes Care
, vol.35
, pp. e7
-
-
Yamauchi, K.1
-
45
-
-
37349104226
-
Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema
-
Byrd, J. B. et al. Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. Hypertension 51, 141-147 (2008).
-
(2008)
Hypertension
, vol.51
, pp. 141-147
-
-
Byrd, J.B.1
-
46
-
-
34547133028
-
Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema
-
Byrd, J. B. et al. Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema. J Allergy Clin Immunol 120, 403-408 (2007).
-
(2007)
J Allergy Clin Immunol
, vol.120
, pp. 403-408
-
-
Byrd, J.B.1
-
47
-
-
79251623618
-
Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males
-
Herman, G. A. et al. Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males. Br J Clin Pharmacol 71, 429-436 (2011).
-
(2011)
Br J Clin Pharmacol
, vol.71
, pp. 429-436
-
-
Herman, G.A.1
-
48
-
-
41649083174
-
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes
-
Covington, P. et al. Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes. Clin Ther 30, 499-512 (2008).
-
(2008)
Clin Ther
, vol.30
, pp. 499-512
-
-
Covington, P.1
-
49
-
-
41649102998
-
Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects
-
Christopher, R. et al. Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects. Clin Ther 30, 513-527 (2008).
-
(2008)
Clin Ther
, vol.30
, pp. 513-527
-
-
Christopher, R.1
-
50
-
-
84855610542
-
Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning
-
Schwaiger, E. et al. Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning. Exp Hematol 40, 97-106 (2012).
-
(2012)
Exp Hematol
, vol.40
, pp. 97-106
-
-
Schwaiger, E.1
-
51
-
-
78249259703
-
Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts
-
Zhang, D. et al. Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts. Am J Physiol Heart Circ Physiol 299, H1339-1347 (2010).
-
(2010)
Am J Physiol Heart Circ Physiol
, vol.299
, pp. H1339-1347
-
-
Zhang, D.1
-
52
-
-
4043117769
-
Modulation of hematopoietic stem cell homing and engraftment by CD26
-
Christopherson, K. W., 2nd, Hangoc, G., Mantel, C. R. & Broxmeyer, H. E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305, 1000-1003 (2004).
-
(2004)
Science
, vol.305
, pp. 1000-1003
-
-
Christopherson, K.W.1
Hangoc, G.2
Mantel, C.R.3
Broxmeyer, H.E.4
-
53
-
-
84863647785
-
Current trends in the pharmacotherapy of diabetic retinopathy
-
Kumar, B., Gupta, S. K., Saxena, R. & Srivastava, S. Current trends in the pharmacotherapy of diabetic retinopathy. J Postgrad Med 58, 132-139 (2012).
-
(2012)
J Postgrad Med
, vol.58
, pp. 132-139
-
-
Kumar, B.1
Gupta, S.K.2
Saxena, R.3
Srivastava, S.4
-
54
-
-
0037277741
-
Vascular endothelial growth factors and angiogenesis in eye disease
-
Witmer, A. N., Vrensen, G. F., Van Noorden, C. J. & Schlingemann, R. O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22, 1-29 (2003).
-
(2003)
Prog Retin Eye Res
, vol.22
, pp. 1-29
-
-
Witmer, A.N.1
Vrensen, G.F.2
Van Noorden, C.J.3
Schlingemann, R.O.4
-
55
-
-
77952889192
-
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: Report 2
-
e1072
-
Michaelides, M. et al. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology 117, 1078-1086 e1072 (2010).
-
(2010)
Ophthalmology
, vol.117
, pp. 1078-1086
-
-
Michaelides, M.1
-
56
-
-
70349705635
-
Phosphorylation of caveolin-1 regulates oxidant-induced pulmonary vascular permeability via paracellular and transcellular pathways
-
615 p following 685
-
Sun, Y., Hu, G., Zhang, X. & Minshall, R. D. Phosphorylation of caveolin-1 regulates oxidant-induced pulmonary vascular permeability via paracellular and transcellular pathways. Circ Res 105, 676-685, 615 p following 685 (2009).
-
(2009)
Circ Res
, vol.105
, pp. 676-685
-
-
Sun, Y.1
Hu, G.2
Zhang, X.3
Minshall, R.D.4
-
57
-
-
84897402975
-
Twist1 controls lung vascular permeability and endotoxin-induced pulmonary edema by altering Tie2 expression
-
Mammoto, T. et al. Twist1 controls lung vascular permeability and endotoxin-induced pulmonary edema by altering Tie2 expression. PLoS One 8, e73407 (2013).
-
(2013)
PLoS One
, vol.8
, pp. e73407
-
-
Mammoto, T.1
-
58
-
-
84864628161
-
Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-beta1/ERK/caspase-9 phosphorylation cascade
-
Lee, S. W. et al. Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-beta1/ERK/caspase-9 phosphorylation cascade. Mol Med 17, 1095-1106 (2011).
-
(2011)
Mol Med
, vol.17
, pp. 1095-1106
-
-
Lee, S.W.1
-
59
-
-
84872371391
-
Hypoxia-reoxygenation-induced endothelial barrier failure: Role of RhoA, Rac1 and myosin light chain kinase
-
Aslam, M. et al. Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase. J Physiol 591, 461-473 (2013).
-
(2013)
J Physiol
, vol.591
, pp. 461-473
-
-
Aslam, M.1
-
60
-
-
0022614794
-
Isolation, growth requirements, cloning, prostacyclin production and life-span of human adult endothelial cells in low serum culture medium
-
Hoshi, H. & McKeehan, W. L. Isolation, growth requirements, cloning, prostacyclin production and life-span of human adult endothelial cells in low serum culture medium. In Vitro Cell Dev Biol 22, 51-56 (1986).
-
(1986)
Vitro Cell Dev Biol
, vol.22
, pp. 51-56
-
-
Hoshi, H.1
McKeehan, W.L.2
|